FBIO
Price:
$1.61
Market Cap:
$44.44M
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the ...[Read more]
Industry
Biotechnology
IPO Date
2011-11-17
Stock Exchange
NASDAQ
Ticker
FBIO
According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.23. This represents a change of -7.44% compared to the average of 1.33 of the last 4 quarters.
The mean historical Current Ratio of Fortress Biotech, Inc. over the last ten years is 4.89. The current 1.23 Current Ratio has changed 2.41% with respect to the historical average. Over the past ten years (40 quarters), FBIO's Current Ratio was at its highest in in the December 2014 quarter at 17.28. The Current Ratio was at its lowest in in the June 2023 quarter at 0.99.
Average
4.89
Median
3.07
Minimum
1.38
Maximum
17.28
Discovering the peaks and valleys of Fortress Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 93.68%
Maximum Annual Current Ratio = 17.28
Minimum Annual Increase = -79.45%
Minimum Annual Current Ratio = 1.38
Year | Current Ratio | Change |
---|---|---|
2023 | 1.38 | -23.61% |
2022 | 1.80 | -47.38% |
2021 | 3.43 | -37.13% |
2020 | 5.45 | 59.22% |
2019 | 3.43 | 71.30% |
2018 | 2.00 | -26.39% |
2017 | 2.72 | 40.17% |
2016 | 1.94 | -79.45% |
2015 | 9.43 | -45.43% |
2014 | 17.28 | 93.68% |
The current Current Ratio of Fortress Biotech, Inc. (FBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.20
5-year avg
3.10
10-year avg
4.89
Fortress Biotech, Inc.’s Current Ratio is greater than Mustang Bio, Inc. (0.40), less than Achilles Therapeutics plc (6.04), greater than Aptose Biosciences Inc. (1.05), less than Fortress Biotech, Inc. (1.23), greater than Checkpoint Therapeutics, Inc. (0.29), less than Avenue Therapeutics, Inc. (2.67), less than Pieris Pharmaceuticals, Inc. (4.82), less than Aileron Therapeutics, Inc. (3.30), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Eyenovia, Inc. (0.74), less than Cognition Therapeutics, Inc. (2.11), less than TransCode Therapeutics, Inc. (1.58), less than Kodiak Sciences Inc. (8.42), less than XOMA Corporation (7.52), greater than ZIVO Bioscience, Inc. (0.17), less than Lumos Pharma, Inc. (2.66), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Athira Pharma, Inc. (2.95), less than ACADIA Pharmaceuticals Inc. (2.29), less than Cabaletta Bio, Inc. (8.11),
Company | Current Ratio | Market cap |
---|---|---|
0.40 | $9.63M | |
6.04 | $43.57M | |
1.05 | $3.71M | |
1.23 | $42.11M | |
0.29 | $180.50M | |
2.67 | $3.84M | |
4.82 | $22.15M | |
3.30 | $53.51M | |
0.41 | $40.63M | |
0.74 | $9.30M | |
2.11 | $17.77M | |
1.58 | $6.64M | |
8.42 | $325.74M | |
7.52 | $353.53M | |
0.17 | $74.08M | |
2.66 | $37.28M | |
0.41 | $38.12M | |
2.95 | $24.83M | |
2.29 | $2.72B | |
8.11 | $91.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Fortress Biotech, Inc.'s Current Ratio?
How is the Current Ratio calculated for Fortress Biotech, Inc. (FBIO)?
What is the highest Current Ratio for Fortress Biotech, Inc. (FBIO)?
What is the 3-year average Current Ratio for Fortress Biotech, Inc. (FBIO)?
What is the 5-year average Current Ratio for Fortress Biotech, Inc. (FBIO)?
How does the current Current Ratio for Fortress Biotech, Inc. (FBIO) compare to its historical average?